SYNTA PHARMACEUTICALS CORP's ticker is SNTA and the CUSIP is 87162T206.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $19,000 | -29.6% | 77,700 | 0.0% | 0.00% | – |
| Q4 2015 | $27,000 | -80.3% | 77,700 | -1.2% | 0.00% | – |
| Q3 2015 | $137,000 | -21.7% | 78,624 | 0.0% | 0.00% | – |
| Q2 2015 | $175,000 | +136.5% | 78,624 | +105.2% | 0.00% | – |
| Q1 2015 | $74,000 | 0.0% | 38,324 | +37.7% | 0.00% | – |
| Q4 2014 | $74,000 | -36.2% | 27,824 | -27.8% | 0.00% | – |
| Q3 2014 | $116,000 | +18.4% | 38,524 | +61.0% | 0.00% | – |
| Q2 2014 | $98,000 | -50.0% | 23,924 | -47.4% | 0.00% | – |
| Q1 2014 | $196,000 | -22.8% | 45,445 | -6.3% | 0.00% | – |
| Q4 2013 | $254,000 | -36.8% | 48,524 | -23.8% | 0.00% | – |
| Q3 2013 | $402,000 | -33.8% | 63,667 | -47.7% | 0.00% | -100.0% |
| Q2 2013 | $607,000 | – | 121,707 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 21,704,847 | $5,209,000 | 7.19% |
| CAXTON CORP | 67,000 | $16,000 | 0.02% |
| McQueen, Ball & Associates Inc. | 102,742 | $25,000 | 0.02% |
| TWO SIGMA SECURITIES, LLC | 36,056 | $9,000 | 0.01% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1,398,330 | $336,000 | 0.01% |
| WEDBUSH SECURITIES INC | 45,000 | $11,000 | 0.00% |
| Roundview Capital LLC | 21,100 | $5,000 | 0.00% |
| Renaissance Technologies | 2,332,995 | $560,000 | 0.00% |
| PANAGORA ASSET MANAGEMENT INC | 618,599 | $148,000 | 0.00% |
| Virtu KCG Holdings LLC | 107,071 | $26,000 | 0.00% |